These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17262189)

  • 21. The effects of levosimendan vs dobutamine added to dopamine on liver functions assessed with noninvasive liver function monitoring in patients with septic shock.
    Memiş D; Inal MT; Sut N
    J Crit Care; 2012 Jun; 27(3):318.e1-6. PubMed ID: 21855289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of levosimendan in sepsis and septic shock.
    Pinto BB; Rehberg S; Ertmer C; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for levosimendan.
    De Keulenaer BL
    Crit Care Resusc; 2008 Sep; 10(3):180. PubMed ID: 18798714
    [No Abstract]   [Full Text] [Related]  

  • 24. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
    Bhattacharjee S; Soni KD; Maitra S; Baidya DK
    J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
    Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?
    Parissis JT; Farmakis D; Kremastinos DT
    Eur J Heart Fail; 2006 Mar; 8(2):215; author reply 218. PubMed ID: 16442844
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasopressin, levosimendan, and cardiovascular function in septic shock.
    Russell JA
    Crit Care Med; 2010 Oct; 38(10):2071-3. PubMed ID: 20855998
    [No Abstract]   [Full Text] [Related]  

  • 28. Levosimendan in septic cardiac failure.
    Noto A; Giacomini M; Palandi A; Stabile L; Reali-Forster C; Iapichino G
    Intensive Care Med; 2005 Jan; 31(1):164-5. PubMed ID: 15580334
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment.
    Rafouli-Stergiou P; Parissis JT; Farmakis D; Bistola V; Frogoudaki A; Vasiliadis K; Ikonomidis I; Paraskevaidis I; Kremastinos D; Filippatos G; Lekakis J
    J Cardiovasc Med (Hagerstown); 2017 Oct; 18(10):771-773. PubMed ID: 25643197
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined arginine vasopressin and levosimendan: a promising therapy for septic shock.
    Yang JJ; Wang X; Ji MH; Peng YG
    Crit Care Med; 2011 Apr; 39(4):921-2; author reply 922. PubMed ID: 21613859
    [No Abstract]   [Full Text] [Related]  

  • 31. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
    Elahi MM; Lam J; Asopa S; Matata BM
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Creteur J; Bouckaert Y; Mélot C; Vincent JL
    Intensive Care Med; 2006 May; 32(5):790; author reply 791-2. PubMed ID: 16555067
    [No Abstract]   [Full Text] [Related]  

  • 33. [Levosimendan].
    Michels G; Herzig S; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(43):2444-6. PubMed ID: 16240243
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levosimendan for treatment of septic shock: homeotherapy or inadequate therapy?
    Yang JJ; Ji MH; Sun J; Peng YG
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1147; author reply 1147-8. PubMed ID: 22092214
    [No Abstract]   [Full Text] [Related]  

  • 36. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Levosimendan--an alternative to conventional inotropic treatment of patients with acute heart failure?].
    Rasmussen T; Schmidt H
    Ugeskr Laeger; 2006 Jan; 168(3):261-5. PubMed ID: 16430807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
    Pagel PS
    Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077
    [No Abstract]   [Full Text] [Related]  

  • 39. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure.
    Berger R; Moertl D; Huelsmann M; Bojic A; Ahmadi R; Heissenberger I; Pacher R
    Eur J Heart Fail; 2007 Feb; 9(2):202-8. PubMed ID: 16859992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inotropic support in the NICU: ever more compounds in search of guidance? Commentary on J. Esch et al.: differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation (Neonatology 2012;101:192–200) and M.P. De Carolis et al.: levosimendan in two neonates with ischemic heart failure and pulmonary hypertension (Neonatology 2012;101:201–205).
    Thewissen L; Allegaert K
    Neonatology; 2012; 101(3):206-9. PubMed ID: 22067565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.